Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Zhigang Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7030-7804; OpenAlex author ID A5101419312. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

  1. RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancer. Last author DOI 10.1186/s12935-019-1077-6↗
  2. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Co-author DOI 10.1016/j.diabres.2014.04.007↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaomeng Zhang · 1 shared paper, 2019 · strength 0.12
  2. Jiandong Zhao · 1 shared paper, 2014 · strength 0.04
  3. Zheng Wang · 1 shared paper, 2014 · strength 0.04
  4. Guoliang Jiang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.